|
1-Pyrrolidineacetamide, α-ethyl-2-oxo-
|
|
(2R)-2-(2-Oxo-1-pyrrolidinyl)butanimidic acid
|
|
1-Pyrrolidineethanimidic acid, α-ethyl-2-oxo-, (αR)-
|
|
Etiracetam, R-(+)-
|
|
(±)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
|
|
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
|
|
T5NVTJ AY2&VZ
|
|
(R)-2-(2-oxopyrrolidin-1-yl)butanamide
|
|
Etiracetam
|
|
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)-
|
|
2-(2-Oxo-1-pyrrolidinyl)butanamide
|
|
α-Ethyl-2-oxo-1-pyrrolidineacetamide
|
|
UNII:230447L0GL
|
|
C8H14N2O2
|
|
Torleva
|
|
乙拉西坦
|
|
2-(2-Oxopyrrolidin-1-yl)butyramide
|
|
ucb L060
|
|
(±)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
|
|
Leviteracetam
|
|
(2R)-2-(2-Oxo-1-pyrrolidinyl)butanamide
|
|
2-(2-oxopyrrolidin-1-yl)butanamide
|
|
LEVITIRACETAM
|
|
Levetiracetam Impurity 4
|
